Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by stockman6767on Jul 20, 2017 9:44am
242 Views
Post# 26489834

RE:RE:RE:RE:RE:we would need 4 more people like lynne gagnon

RE:RE:RE:RE:RE:we would need 4 more people like lynne gagnonStaghorn, I think we are pretty much on the same page here, with one minor exception. I think Pierre has made clear that for the MAJOR 4050 indications which as you say are still years off, the goal here is great news from the PIIs going on, with the aim being, snagging a partner with these great PII 4050 results - not to try and carry this on their own to commercialization for which all agree will need deep pockets of a major pharma.

Glta
Stockman6767
Bullboard Posts